Research

Researchers led by Dr. Michael Pawlak from NMI Technologie Transfer GmbH (NMI TT) in Reutlingen and Prof. Dr. Hans Neubauer from the Women’s Hospital at the University of Düsseldorf have developed a new method that enables a more precise analysis of individual tumor cells circulating in the blood. This allows not only the previously possible […]

CAVIGEN develops thermoformed microstructures for cell culture, including microcavities, porous microcavities, sensor-integrated microcavities (sensor arrays), and microchannels. Its patented technology enables precise oxygen measurement in 3D cell cultures, enhancing the physiological relevance of in vitro models, improving drug development processes, and reducing the need for animal testing. CAVIGEN’s business model follows a razor-and-blade approach, offering […]

Nicht nur in der Versorgung, sondern auch in der Wirtschaft fehlen Fachkräfte in der Gesundheitsindustrie. Bei einer Podiumsdiskussion am 11. März 2025, die am Vortag der Jobmesse T5 in Stuttgart stattfindet, will das Forum Gesundheitsstandort Baden-Württemberg zu den Themen Fachkräfte gewinnen, Wirtschaft stärken und Gesundheit fördern diskutieren. Ob Medizintechnik, Pharma oder Biotechnologie – Baden-Württemberg ist […]

Müller, E.; Enzlein, T.; Niemeyer, D.; von Ammon, L.; Stumpo, K.; Biber, K.; Klein, C.; Hopf, C. Exploring the Aβ Plaque Microenvironment in Alzheimer’s Disease Model Mice by Multimodal Lipid-Protein-Histology Imaging on a Benchtop Mass Spectrometer. Pharmaceuticals 2025, 18, 252. https://doi.org/10.3390/ph18020252 Abstract Amyloid-β (Aβ) plaque deposits in the brain are a hallmark of Alzheimer’s disease (AD) neuropathology. Plaques […]

Approval based on positive results from Phase III ATTRibute-CM study / Beyonttra™ is a near-complete (≥90%) stabilizer of transthyretin (TTR) minimizing amyloid formation / Phase III ATTRibute-CM study with Beyonttra™ has shown clear benefits on cardiovascular endpoints already starting as early as 3 months after treatment initiation Berlin, February 11, 2025 – The European Commission has […]

Researchers have increased the resolution in fluorescence microscopy by a factor of 30 without having to sequentially switch fluorescent molecules between light and dark states. The Nobel Prize-winning STED and PALM/STORM microscopes, as well as other super-resolution fluorescence microscopes, provide resolutions of a fraction of the wavelength of light. However, to image adjacent fluorescent molecules […]

International project consortium is coordinated at Heidelberg University Targeted molecular interventions in the replication cycle and the immune recognition of viruses are intended to prevent viral entry into cells and virus replication. That is the goal of an international research project in which scientists work on new approaches to combating highly dangerous viral diseases such […]

The results from a phase 3 trial involving 662 patients from 67 clinics led by Heidelberg University Hospital and the Heidelberg Medical Faculty at Heidelberg University indicate that a new immunotherapeutic approach keeps the disease under control for longer. The data has just been published in the Journal of Clinical Oncology. The study has been […]

February 19, 2025 Basel, Switzerland, 19 February 2025 – Celonic Group, a “Pure Play” biologics contract development and manufacturing organization (CDMO), announced today the signing of a multi-year commercial manufacturing agreement with LINDIS Biotech for the production of catumaxomab for Commercial Supply. Catumaxomab is a first-in-class, trifunctional bispecific monoclonal antibody designed for the intraperitoneal treatment of […]